Guanze Medical (02427) Announces February 2026 Securities Movement Update

Bulletin Express
03/03

Guanze Medical Information Industry (Holding) Co., Ltd. (02427) released its monthly return for the period ended 28 February 2026, showing that the total authorized share capital remained at HKD 100,000,000, comprising 10,000,000,000 ordinary shares with a par value of HKD 0.01. The number of issued shares also stayed unchanged at 950,000,000 shares.

According to the document, no new share options, warrants, or convertible securities were issued during the reporting period, and the minimum public float requirement of 25% was confirmed to be satisfied. The submission, dated 3 March 2026, indicated no movement in share capital or treasury shares for February.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10